$MSM
MSC INDUSTRIAL DIRECT CO INC

2023 Q4 Form 10-Q Financial Statement

#000100307824000008 Filed on January 09, 2024

View on sec.gov

Income Statement

Concept 2023 Q4
Revenue $954.0M
YoY Change -0.39%
Cost Of Revenue $560.9M
YoY Change 0.16%
Gross Profit $393.1M
YoY Change -1.18%
Gross Profit Margin 41.21%
Selling, General & Admin $5.201M
YoY Change 4.23%
% of Gross Profit 1.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $19.78M
YoY Change 6.55%
% of Gross Profit 5.03%
Operating Expenses $290.6M
YoY Change 3.91%
Operating Profit $101.6M
YoY Change -12.45%
Interest Expense $5.320M
YoY Change -23.11%
% of Operating Profit 5.24%
Other Income/Expense, Net -$10.25M
YoY Change 25.63%
Pretax Income $91.32M
YoY Change -15.33%
Income Tax $22.19M
% Of Pretax Income 24.3%
Net Earnings $69.35M
YoY Change -14.71%
Net Earnings / Revenue 7.27%
Basic Earnings Per Share $1.23
Diluted Earnings Per Share $1.22
COMMON SHARES
Basic Shares Outstanding 57.24M shares
Diluted Shares Outstanding 56.72M shares

Balance Sheet

Concept 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.81M
YoY Change -2.0%
Cash & Equivalents $25.81M
Short-Term Investments
Other Short-Term Assets $121.5M
YoY Change 1.26%
Inventory $709.4M
Prepaid Expenses
Receivables $414.3M
Other Receivables $0.00
Total Short-Term Assets $1.271B
YoY Change -18.45%
LONG-TERM ASSETS
Property, Plant & Equipment $322.1M
YoY Change 8.41%
Goodwill $718.3M
YoY Change 1.21%
Intangibles $106.9M
YoY Change -3.44%
Long-Term Investments
YoY Change
Other Assets $14.38M
YoY Change 37.45%
Total Long-Term Assets $1.223B
YoY Change 2.68%
TOTAL ASSETS
Total Short-Term Assets $1.271B
Total Long-Term Assets $1.223B
Total Assets $2.494B
YoY Change -9.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $189.0M
YoY Change -11.19%
Accrued Expenses $174.1M
YoY Change 2.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $244.0M
YoY Change -25.19%
Total Short-Term Liabilities $627.9M
YoY Change -13.61%
LONG-TERM LIABILITIES
Long-Term Debt $294.4M
YoY Change -35.13%
Other Long-Term Liabilities $41.41M
YoY Change -9.37%
Total Long-Term Liabilities $335.8M
YoY Change -26.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $627.9M
Total Long-Term Liabilities $335.8M
Total Liabilities $1.095B
YoY Change -18.91%
SHAREHOLDERS EQUITY
Retained Earnings $465.0M
YoY Change -33.91%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $115.4M
YoY Change 5.3%
Treasury Stock Shares
Shareholders Equity $1.385B
YoY Change
Total Liabilities & Shareholders Equity $2.494B
YoY Change -9.3%

Cashflow Statement

Concept 2023 Q4
OPERATING ACTIVITIES
Net Income $69.35M
YoY Change -14.71%
Depreciation, Depletion And Amortization $19.78M
YoY Change 6.55%
Cash From Operating Activities $81.17M
YoY Change 6.77%
INVESTING ACTIVITIES
Capital Expenditures $18.43M
YoY Change -27.73%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$18.43M
YoY Change -27.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$87.19M
YoY Change 28.32%
NET CHANGE
Cash From Operating Activities $81.17M
Cash From Investing Activities -$18.43M
Cash From Financing Activities -$87.19M
Net Change In Cash -$24.25M
YoY Change 40.92%
FREE CASH FLOW
Cash From Operating Activities $81.17M
Capital Expenditures $18.43M
Free Cash Flow $62.74M
YoY Change 24.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
560852000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
559946000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
393117000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
397799000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
290633000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
279695000 usd
CY2023Q4 us-gaap Restructuring Costs
RestructuringCosts
916000 usd
CY2022Q4 us-gaap Restructuring Costs
RestructuringCosts
2094000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
101568000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
116010000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
5320000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
6919000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
125000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
100000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5055000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1340000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10250000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8159000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
91318000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
107851000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22190000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26639000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
69128000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
81212000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-222000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-102000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
69350000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
81314000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.45
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.45
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56429000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55891000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56723000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56081000 shares
CY2023Q4 us-gaap Profit Loss
ProfitLoss
69128000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
81212000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
404000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1270000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
69532000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
82482000 usd
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-222000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-102000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-44000 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
335000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
69798000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
82249000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1398225000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1398420000 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
69128000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
81212000 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19782000 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18566000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5559000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4872000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
5201000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
4990000 usd
CY2023Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-98000 usd
CY2022Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-229000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
220000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2023Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
90000 usd
CY2022Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2673000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21170000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-56000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17218000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9516000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16036000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22764000 usd
CY2023Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5717000 usd
CY2022Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4843000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2132000 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-33413000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1057000 usd
CY2023Q4 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
12040000 usd
CY2022Q4 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-5188000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81168000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76024000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18433000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25504000 usd
CY2023Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
87000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18433000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25591000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
132045000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
18539000 usd
CY2023Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
47192000 usd
CY2022Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
44207000 usd
CY2023Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1144000 usd
CY2022Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1056000 usd
CY2023Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6852000 usd
CY2022Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8336000 usd
CY2023Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
148000000 usd
CY2022Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
84000000 usd
CY2023Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
65000000 usd
CY2022Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
99000000 usd
CY2023Q4 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1624000 usd
CY2022Q4 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1061000 usd
CY2023Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-574000 usd
CY2022Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-657000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-87191000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-67950000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
311000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24247000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17206000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50052000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43537000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25805000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26331000 usd
CY2023Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
5454000 usd
CY2022Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
2767000 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
4882000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
5441000 usd
CY2023Q4 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Year</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates on a 52/53-week fiscal year ending on the Saturday closest to August 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. References to “fiscal year 2024” refer to the period from September 3, 2023 to August 31, 2024, which is a 52-week fiscal year. References to “fiscal year 2023” refer to the period from September 4, 2022 to September 2, 2023, which is a 52-week fiscal year. The fiscal quarters ended December 2, 2023 and December 3, 2022 refer to the thirteen weeks ended as of those dates.</span></div>
CY2023Q4 msm Accrued Sales Returns
AccruedSalesReturns
8553000 usd
CY2023Q3 msm Accrued Sales Returns
AccruedSalesReturns
8632000 usd
CY2023Q4 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
29105000 usd
CY2023Q3 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
31954000 usd
CY2023Q4 msm Revenue Recognition Prepaid Sales Incentives
RevenueRecognitionPrepaidSalesIncentives
3575000 usd
CY2023 msm Revenue Recognition Prepaid Sales Incentives
RevenueRecognitionPrepaidSalesIncentives
3733000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2023Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
434551000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
458168000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
69350000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
81314000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56429000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55891000 shares
CY2023Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
294000 shares
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
190000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56723000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56081000 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.23
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.45
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.45
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
499000 shares
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
5201000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
4990000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1264000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1233000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3937000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3757000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
218000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
81.60
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
86000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
79.96
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
132000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
82.67
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2141000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
132000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
82.67
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y8M12D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2141000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2022Q4 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
0 usd
CY2023Q4 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
0 usd
CY2022Q4 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0 usd
CY2023Q4 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20271000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22747000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
414280000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
435421000 usd
CY2022Q4 msm Accounts Receivable Amount Authorized For Sale
AccountsReceivableAmountAuthorizedForSale
300000000 usd
CY2023Q4 msm Accounts Receivable Sales Transactions Fees
AccountsReceivableSalesTransactionsFees
4611000 usd
CY2022Q4 msm Accounts Receivable Sales Transactions Fees
AccountsReceivableSalesTransactionsFees
0 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4750000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
4750000 usd
CY2023Q4 msm Financing Obligations
FinancingObligations
1336000 usd
CY2023Q3 msm Financing Obligations
FinancingObligations
127000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
329000 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
475000 usd
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
937000 usd
CY2023Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1026000 usd
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
538478000 usd
CY2023Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
454326000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
244048000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
229935000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
294430000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
224391000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
135000 usd
CY2023Q4 us-gaap Deferred Finance Costs Current Gross
DeferredFinanceCostsCurrentGross
348000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
249000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
249000 usd
CY2023Q3 us-gaap Deferred Finance Costs Current Gross
DeferredFinanceCostsCurrentGross
351000 usd
CY2023Q4 msm Number Of Credit Facilities
NumberOfCreditFacilities
3 facility
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
132045000 usd
CY2023Q4 us-gaap Stock Issued During Period Shares Employee Stock Ownership Plan
StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
13000 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Employee Stock Ownership Plan
StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
14000 shares
CY2023Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.83
CY2023Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
47192000 usd
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.79
CY2022Q4 us-gaap Dividends
Dividends
44207000 usd
CY2023Q4 msm Number Of Individuals Eligible For Nomination
NumberOfIndividualsEligibleForNomination
2 individual
CY2023Q4 msm Common Stock Ownership Percentage Threshold Two Board Member Nomination
CommonStockOwnershipPercentageThresholdTwoBoardMemberNomination
0.10
CY2023Q4 msm Common Stock Ownership Percentage Threshold Transferee Percentage
CommonStockOwnershipPercentageThresholdTransfereePercentage
0.15
CY2023Q4 msm Restructuring Charges Consulting Related Costs
RestructuringChargesConsultingRelatedCosts
76000 usd
CY2022Q4 msm Restructuring Charges Consulting Related Costs
RestructuringChargesConsultingRelatedCosts
1575000 usd
CY2023Q4 us-gaap Severance Costs1
SeveranceCosts1
736000 usd
CY2022Q4 us-gaap Severance Costs1
SeveranceCosts1
519000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
104000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
0 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
916000 usd
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
2094000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
1137000 usd
CY2023Q4 msm Consulting And Severance Costs
ConsultingAndSeveranceCosts
812000 usd
CY2023Q4 us-gaap Payments For Restructuring
PaymentsForRestructuring
876000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
1073000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
msm-20231202_def.xml Edgar Link unprocessable
msm-20231202_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001003078-24-000008-index-headers.html Edgar Link pending
0001003078-24-000008-index.html Edgar Link pending
msm-20231202_cal.xml Edgar Link unprocessable
0001003078-24-000008.txt Edgar Link pending
0001003078-24-000008-xbrl.zip Edgar Link pending
exhibit102formofrestricted.htm Edgar Link pending
exhibit103formofperformanc.htm Edgar Link pending
exhibit104executiveseveran.htm Edgar Link pending
exhibit105mscindustrialdir.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_1.jpg Edgar Link pending
image_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
msm-20231202.htm Edgar Link pending
msm-20231202.xsd Edgar Link pending
msm-20231202xex311.htm Edgar Link pending
msm-20231202xex312.htm Edgar Link pending
msm-20231202xex321.htm Edgar Link pending
msm-20231202xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
msm-20231202_lab.xml Edgar Link unprocessable
msm-20231202_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending